Due to COVID-19, HCA’s lobby is closed. Learn more about your customer service options.

General Health Care Authority rulemaking

This page includes all of the current rule making activity for General Health Care Authority.

Patient Decision Aids
Patient decision aids
Affected WAC: 182-60-027, 182-60-040
Pending formal proposal
Filed date:04/27/2021
Description: HCA is amending WAC 182-60-027 to add patient representative to the list of panel members. Patient representatives add value to HCA’s patient decision aid (PDA) review advisory panels. After conducting several rounds of certification and recertification, HCA has determined that two years is too short of a time frame between the initial certification of a patient decision aid and its recertification. Therefore, HCA is amending 182-60-040 to change the length of time for certification of patient decision aids from two years to four years.
Agency contact:
Jason Crabbe, rule writer
360-725-9563
Preproposal (CR101) - WSR 21-10-030
Filed date:04/27/2021
All Payor Claims Database
Registration requirements
Affected WAC: 182-70-040
Pending formal proposal
Filed date: 2/1/2021
Description: HCA is adding a definition of de minimis to the section to specify a minimum reporting threshold below which a data supplier is not required to submit data.
Agency contact:
Jason Crabbe, rule writer
360-725-9563
Preproposal (CR101) - WSR 21-04-121
Filed date: 2/1/2021
All Payor Claims Database
All Payor Claims Database
Affected WAC: Chapter 182-70
Formally proposed
Effective:4/25/2020
Description: Engrossed Substitute Senate Bill 5741 (66th Legislature, 2019 Regular Session) amended sections of Chapter 43.371 RCW to transfer authority and oversight of the state All-Payer Health Care Claims Database from the Office of Financial Management to the Health Care Authority, effective January 1, 2020. To implement this transfer, the rules were recodified to Chapter 182-70, under WSR 19-24-090. The Health Care Authority is filing these rules to replace: • References to the Office of Financial Management with the Health Care Authority; and • Citations to sections of Chapter 82-75 WAC with sections of Chapter 182-70 WAC. The Health Care Authority has not made any material changes to these rules.
Agency contact:
Melinda Froud, rule writer
360-725-1408
Expedited Adoption (CR105) - WSR 20-03-074
Filed: 1/10/2020
Permanent Adoption (CR103P) - WSR 20-08-059
Effective:4/25/2020
Washington Rx Drug Pricing Program
Manufacturers - data and price reporting & data confidentiality
Affected WAC: 182-51-0600, 182-51-0900
Formally proposed
Effective: 05/23/2021
Description: HCA is amending WAC 182-51-0600 to change the timeframe manufacturers have to report to HCA new covered drugs being introduced to market in Washington. HCA is also amending WAC 182-51-0900 to add the contents of the Prescription Drug Pricing Transparency program’s nondisclosure agreement.
Agency contact:
Jason Crabbe, rule writer
360-725-9563
Preproposal (CR101) - WSR 20-22-098
Filed date: 11/3/2020
Proposal (CR102) - WSR 21-06-099
Hearing date: 4/6/2021
*Comments due 4/6/2021
Permanent Adoption (CR103P) - WSR 21-10-008
Effective: 05/23/2021
Washington Rx Drug Pricing Program
Washington Prescription Drug Pricing Program
Affected WAC: Chapter 182-51
Formally proposed
Effective: 10/16/2020
Description: To implement the Washington Prescription Drug Pricing Transparency Program as required under Chapter 43.71C RCW.
Agency contact:
Jason Crabbe, rule writer
360-725-9563
Preproposal (CR101) - WSR 20-03-078
Filed: 1/10/2020
Proposal (CR102) - WSR 20-15-146
Hearing Date: 8/25/2020
*Comments due by 8/25/2020
Permanent Adoption (CR103P) - WSR 20-19-079
Effective: 10/16/2020